BR9712197A - Formulação farmacêutica líquida aquosa e processos de preparação da mesma, e, de inibição de reabsorção de osso. - Google Patents

Formulação farmacêutica líquida aquosa e processos de preparação da mesma, e, de inibição de reabsorção de osso.

Info

Publication number: BR9712197A
Authority: BR; Brazil
Prior art keywords: processes; pharmaceutical formulation; preparing; liquid pharmaceutical; aqueous liquid
Prior art date: 1996-10-04

Application number

BR9712197-5A

Other languages

English (en)

Portuguese (pt)

Inventor

Maneesh J Nerurkaar

William H Hunke

Drazen Ostovic

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-04

Filing date

1997-10-02

Publication date

1999-08-31

1997-01-13 Priority claimed from GBGB9700541.7A external-priority patent/GB9700541D0/en

1997-10-02 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1999-08-31 Publication of BR9712197A publication Critical patent/BR9712197A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BR9712197-5A 1996-10-04 1997-10-02 Formulação farmacêutica líquida aquosa e processos de preparação da mesma, e, de inibição de reabsorção de osso. BR9712197A (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US2676596P	1996-10-04	1996-10-04
GBGB9700541.7A GB9700541D0 (en)	1997-01-13	1997-01-13	Liquid alendronate formulation
US3600297P	1997-01-22	1997-01-22
PCT/US1997/015740 WO1998014196A1 (en)	1996-10-04	1997-10-02	Liquid alendronate formulations

Publications (1)

Publication Number	Publication Date
BR9712197A true BR9712197A (pt)	1999-08-31

Family

ID=27268667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9712197-5A BR9712197A (pt)	1996-10-04	1997-10-02	Formulação farmacêutica líquida aquosa e processos de preparação da mesma, e, de inibição de reabsorção de osso.

Country Status (20)

Country	Link
EP (1)	EP1007054A4 (ru)
JP (1)	JP2001501222A (ru)
CN (1)	CN1238691A (ru)
AU (1)	AU723357B2 (ru)
BG (1)	BG103306A (ru)
BR (1)	BR9712197A (ru)
CA (1)	CA2267370A1 (ru)
CZ (1)	CZ116999A3 (ru)
EA (1)	EA001213B1 (ru)
EE (1)	EE03669B1 (ru)
HU (1)	HUP0000125A3 (ru)
IL (1)	IL129127A0 (ru)
IS (1)	IS5012A (ru)
NO (1)	NO991569L (ru)
NZ (1)	NZ334836A (ru)
PL (1)	PL332496A1 (ru)
SK (1)	SK42999A3 (ru)
TR (1)	TR199900730T2 (ru)
WO (1)	WO1998014196A1 (ru)
YU (1)	YU17499A (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7560490B2 (en)	2001-01-23	2009-07-14	Gador S.A.	Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
US7645460B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of risedronate
US7645459B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of bisphosphonates
US20080287400A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US20080286359A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US7473684B2 (en)	2005-09-16	2009-01-06	Selamine Limited	Bisphosphonate formulation
WO2007031785A2 (en) *	2005-09-16	2007-03-22	Selamine Ltd	Bisphosphonate formulation
JP2010043119A (ja) *	2009-10-16	2010-02-25	Gador Sa	骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用
US8568747B1 (en)	2012-10-05	2013-10-29	Silvergate Pharmaceuticals, Inc.	Enalapril compositions
US9463183B1 (en)	2015-10-30	2016-10-11	Silvergate Pharmaceuticals, Inc.	Lisinopril formulations
US9669008B1 (en)	2016-03-18	2017-06-06	Silvergate Pharmaceuticals, Inc.	Enalapril formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4206209A (en) *	1978-11-02	1980-06-03	Kracauer Paul	Sublingual aspirin tablet
IT1201087B (it) *	1982-04-15	1989-01-27	Gentili Ist Spa	Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4922007A (en) *	1989-06-09	1990-05-01	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) *	1990-06-20	1991-05-28	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5270365A (en) *	1991-12-17	1993-12-14	Merck & Co., Inc.	Prevention and treatment of periodontal disease with alendronate
US5358941A (en) *	1992-12-02	1994-10-25	Merck & Co., Inc.	Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (fr) *	1993-04-05	1995-06-30	Sanofi Elf	Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5510517A (en) *	1993-08-25	1996-04-23	Merck & Co., Inc.	Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5462932A (en) *	1994-05-17	1995-10-31	Merck & Co., Inc.	Oral liquid alendronate formulations
US5780455A (en) *	1994-08-24	1998-07-14	Merck & Co., Inc.	Intravenous alendronate formulations
US5616571A (en) *	1995-06-06	1997-04-01	Merck & Co., Inc.	Bisphosphonates prevent bone loss associated with immunosuppressive therapy

1997
- 1997-10-02 EA EA199900352A patent/EA001213B1/ru not_active IP Right Cessation
- 1997-10-02 TR TR1999/00730T patent/TR199900730T2/xx unknown
- 1997-10-02 NZ NZ334836A patent/NZ334836A/xx unknown
- 1997-10-02 HU HU0000125A patent/HUP0000125A3/hu unknown
- 1997-10-02 SK SK429-99A patent/SK42999A3/sk unknown
- 1997-10-02 BR BR9712197-5A patent/BR9712197A/pt unknown
- 1997-10-02 CN CN97180165A patent/CN1238691A/zh active Pending
- 1997-10-02 CZ CZ991169A patent/CZ116999A3/cs unknown
- 1997-10-02 PL PL97332496A patent/PL332496A1/xx unknown
- 1997-10-02 EE EEP199900113A patent/EE03669B1/xx not_active IP Right Cessation
- 1997-10-02 IL IL12912797A patent/IL129127A0/xx unknown
- 1997-10-02 JP JP10516541A patent/JP2001501222A/ja active Pending
- 1997-10-02 CA CA002267370A patent/CA2267370A1/en not_active Abandoned
- 1997-10-02 WO PCT/US1997/015740 patent/WO1998014196A1/en not_active Application Discontinuation
- 1997-10-02 EP EP97945195A patent/EP1007054A4/en not_active Withdrawn
- 1997-10-02 AU AU46448/97A patent/AU723357B2/en not_active Ceased
1999
- 1999-03-26 IS IS5012A patent/IS5012A/is unknown
- 1999-03-30 NO NO991569A patent/NO991569L/no not_active Application Discontinuation
- 1999-03-31 YU YU17499A patent/YU17499A/sr unknown
- 1999-04-02 BG BG103306A patent/BG103306A/xx unknown

Also Published As

Publication number	Publication date
CZ116999A3 (cs)	1999-09-15
EA001213B1 (ru)	2000-12-25
CA2267370A1 (en)	1998-04-09
NO991569L (no)	1999-06-04
JP2001501222A (ja)	2001-01-30
NO991569D0 (no)	1999-03-30
AU723357B2 (en)	2000-08-24
IL129127A0 (en)	2000-02-17
EA199900352A1 (ru)	1999-08-26
HUP0000125A2 (hu)	2000-06-28
YU17499A (en)	1999-11-22
BG103306A (en)	2000-01-31
HUP0000125A3 (en)	2001-04-28
AU4644897A (en)	1998-04-24
EE03669B1 (et)	2002-04-15
CN1238691A (zh)	1999-12-15
PL332496A1 (en)	1999-09-13
EP1007054A4 (en)	2000-07-19
EE9900113A (et)	1999-10-15
SK42999A3 (en)	2000-01-18
NZ334836A (en)	2000-11-24
TR199900730T2 (xx)	1999-07-21
EP1007054A1 (en)	2000-06-14
IS5012A (is)	1999-03-26
WO1998014196A1 (en)	1998-04-09

Similar Documents

Publication	Publication Date	Title
YU69603A (sh)	2006-05-25	Atorvastatin kalcijum u farmaceutskom obliku, njegovoj smeši i farmaceutskoj formulaciji, koja sadrži atorvastatin kalcijum
UA40663C2 (ru)	2001-08-15	Твердая фармацевтическая композиция с регулированным высвобождением лекарственного средства для орального употребления
BR0215240A (pt)	2004-10-26	Derivados de calcona e seu uso no tratamento de doenças
BR0214757A (pt)	2004-09-14	Formulações farmacêuticas de derivados de platina
NZ234143A (en)	1991-10-25	Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
NO20022264D0 (no)	2002-05-13	Farmasöytisk blanding inneholdende tolterodin, samt anvendelse derav
JO3404B1 (ar)	2019-10-20	تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين
KR970706830A (ko)	1997-12-01	2, 2'-디티오-비스(에탄설포네이트)(디메스나)와 조합된 시스플라틴의 조성물(composition of cisplatin in combination with 2, 2＇-dithio-bis (ethanesulfonate) (dimesna)
BR9712197A (pt)	1999-08-31	Formulação farmacêutica líquida aquosa e processos de preparação da mesma, e, de inibição de reabsorção de osso.
BR0008323A (pt)	2002-01-29	Derivado de gabapentina para a prevenção e o tratamento de dor visceral
IL109448A0 (en)	1994-07-31	Risperidone pamoate, its preparation and pharmaceutical compositions containing it
FI110667B (fi)	2003-03-14	Menetelmä farmaseuttisen valmisteen valmistamiseksi
BR9909958A (pt)	2000-12-26	Formulação farmacêutica, respectivos processo de preparação e uso e método de tratamento ou prevenção de distúrbios ósseos
BR9909357A (pt)	2000-12-12	Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina
TR200101163T2 (tr)	2001-08-21	Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
EA199900830A1 (ru)	2000-04-24	Терапевтическая минераловитаминная ассоциация в форме унитарного жидкого препарата для питья
KR910005886A (ko)	1991-04-27	안정화 백혈구 인터페론
PT1218401E (pt)	2004-10-29	4-benzilaminoquinolinas conjugadas com acido biliar e seus heterociclicos metodos de sua producao medicamentos contendo estes compostos e sua aplicacao
LV11524A (lv)	1996-10-20	Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
ATE132003T1 (de)	1996-01-15	Sterilisierende zusammensetzung
HUP0100122A2 (hu)	2002-03-28	Tiludronsav és származékai alkalmazása szárnyasok csontritkulásának megelőzésére és kezelésére szolgáló gyógyászati készítmény előállítására
TH25306A (th)	1997-05-29	วิธีของการใช้สำหรับยับยั้งการสูญเสียกระดูกและการลดคอเลสเทอรอลในซีรัม
SE0000782D0 (sv)	2000-03-09	Pharmaceutical formulation and its use
NO934690D0 (no)	1993-12-17	Anvendelse av atipamezole for behandling av menns impotens
IL141218A0 (en)	2002-03-10	Alendronic acid, pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament or for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any of thereof, all for inhibiting bone resorption

Legal Events

Date	Code	Title	Description
2005-11-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A E 8A ANUIDADES.